PHK
MYGN icon

Point72 Hong Kong’s Myriad Genetics MYGN Stock Holding History

Point72 Hong Kong’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,176
Closed -$32.2K – 540
2024
Q3 		$32.2K Buy
+1,176
New +$31.8K ﹤0.01% 393
2022
Q4 		– Sell
-3,337
Closed -$64K – 1121
2022
Q3 		$64K Buy
3,337
+120
+4% +$2.75K ﹤0.01% 1354
2022
Q2 		$58K Buy
3,217
+2,826
+723% +$58.7K ﹤0.01% 1340
2022
Q1 		$10K Buy
+391
New +$10K ﹤0.01% 1606
2021
Q2 		– Sell
-630
Closed -$19K – 2210
2021
Q1 		$19K Buy
+630
New +$17.9K ﹤0.01% 1483
2020
Q3 		– Sell
-12,138
Closed -$138K – 1407
2020
Q2 		$138K Buy
12,138
+10,639
+710% +$151K 0.02% 573
2020
Q1 		$21K Sell
1,499
-783
-34% -$16.5K 0.01% 540
2019
Q4 		$62K Buy
+2,282
New +$62.8K 0.01% 639
2018
Q4 		– Sell
-211
Closed -$10K – 1096
2018
Q3 		$10K Buy
+211
New +$9.38K ﹤0.01% 663
2018
Q2 		– Sell
-120
Closed -$4K – 1094
2018
Q1 		$4K Buy
+120
New +$4.06K ﹤0.01% 748
2015
Q2 		– Sell
-429
Closed -$15K – 232
2015
Q1 		$15K Sell
429
-1,100
-72% -$39.4K 0.01% 235
2014
Q4 		$52K Buy
+1,529
New +$54.3K 0.05% 390

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Point72 Hong Kong's MYGN Position: Q4 2024 in Review

Point72 Hong Kong sold out of Myriad Genetics (MYGN) in Q4 2024, closing a stake of 1,176 shares — an estimated $32.2K sold.

Point72 Hong Kong first reported a position in MYGN in Q4 2014 and held it in 12 quarters. The position peaked at $138K in Q2 2020. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2024.

  • Point72 Hong Kong reported no remaining Myriad Genetics position as of Q4 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 1,176 Myriad Genetics shares in Q4 2024, an estimated $32.2K.
  • Point72 Hong Kong first reported a position in Myriad Genetics in Q4 2014 and held it in 12 quarters.
  • Point72 Hong Kong's Myriad Genetics position peaked at $138K in Q2 2020.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2024.

Based on Point72 Hong Kong's 13F filing for Q4 2024, filed 14 Feb 2025.